For trials without intervention percutaneous transluminal renal angioplasty (PTRA),
Conditions
Interventions
center retrospective cohort study enrolled transplant renal artery stenosis (TRAS) patients that underwent percutaneous transluminal renal angioplasty (PTRA) or percutaneous transluminal renal angiopl
Treatment
TRAS patients that underwent PTRA or PTRAS treatment
Sponsors
No
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients whom underwent endovascular procedure for TRAS.First-line imaging test to establish the diagnosis of RAS is duplex sonography (DUS) which showed increase in peak systolic velocity > 2 m/s. Other modalities that we also used were CTA and MRA to establish the diagnosis before proceed to invasive angiography.
Exclusion criteria
Exclusion criteria: -The patient with primary or associated acute or chronic allograft rejection. -The patient with primary allograft disease. -The patient with urological complication or infection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical success in terms of renal outcome Time from PTRA/PTRAS to last follow-up visit One-year clinical success and long-term outcome | — |
Secondary
| Measure | Time frame |
|---|---|
| No No No | — |
Countries
Thailand
Contacts
Public ContactNattawut Wongpraparut
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed